Cigna Group (CI) is a healthcare and insurance company offering medical, dental, disability, and life coverage. Market cap is $69 billion. However, CI stock has underperformed, dropping 19.3% in 52 weeks, trailing the S&P 500. Analysts predict an 8.5% increase in EPS for 2025, with a “Strong Buy” consensus rating from Wall Street.

Investor concerns about Cigna’s future business model, especially regarding pharmacy-benefit operations, have impacted CI stock performance. Analysts project an 8.5% YoY increase in EPS for 2025. Wall Street is bullish on CI, with a “Strong Buy” consensus rating. Earlier this month, TD Cowen lowered CI’s price target to $333 from $387, maintaining a “Buy” rating.

Cigna’s mean price target is $336.18, reflecting a 30.2% premium to current levels. The Street-high target of $390 suggests a 51.1% upside potential. CI stock has faced challenges due to investor concerns about its business model and pharmacy-benefit operations. Wall Street remains optimistic, with a “Strong Buy” consensus rating.

Read more at Yahoo Finance: Cigna Group Stock: Analyst Estimates & Ratings